ReviewPharmaceutics2026

Unraveling Vulnerabilities and Pathways Responsible for AITL Malignancy to Improve Patients' Treatment.

Chiara Martinello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.